BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 59.30
-0.70 (-1.17%)
Oct 8, 2026, 1:30 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 2.95 billion as of October 9, 2026. It is the 25,992nd most valuable company in the world and the 1,424th biggest in Taiwan. Its market cap has decreased by 33.54% in one year.
Market Cap
2.95B
Enterprise Value
2.61B
Revenue
1.29B
Global Rank
Country Rank
#1,424 Taiwan
PE Ratio
52.12
ChartMarket Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 2.95B, an increase of 158.40%. That is a compound annual growth rate of 5.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.95B | -43.25% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DIVA Laboratories | 1.83B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.03B |
| Kim Forest Enterprise | 775.93M |
| Sofiva Genomics | 720.14M |
| TFBS Bioscience | 674.33M |
| Welgene Biotech | 395.01M |
| Pharmigene | 352.75M |